P1581: DYNAMICS OF NT-PROBNP LEVEL IN UNRELATED DONORS DURING MOBILIZATION OF HEMATOPOIETIC STEM CELLS

P1581: DYNAMICS OF NT-PROBNP LEVEL IN UNRELATED DONORS DURING MOBILIZATION OF HEMATOPOIETIC STEM CELLS

Bibliographic Details
Main Authors:	Natalia Minaeva, Natalia Zorina, Marina Khorobrikh, Philipp Sherstnev, Tatiana Krivokorytova, Alexander Luchinin, Maksim Minaev, Igor Paramonov
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000973200.44347.ba

Similar Items

P1314: MONITORING OF CIRCULATING CELL FREE DNA IN HEMATOPOIETIC STEM CELL DONORS
by: Tatyana Rybolovleva, et al.
Published: (2023-08-01)

Effect Of Demographic And Clinical Variables On Nt-Probnp
by: Sofia Amjad, et al.
Published: (2018-02-01)

Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD
by: Benedikt Seither, et al.
Published: (2024-11-01)

Immunogenetic characteristics of unrelated hematopoietic stem cell donors recruited in the Sverdlovsk, Saratov, Yaroslavl and Vladimir regions
by: S. S. Kutyavina, et al.
Published: (2020-11-01)

Elevation of NT-proBNP Levels in Pediatric and Young Adult Hematopoietic Stem Cell Transplant Patients with Endotheliopathy
by: Kimberly Uchida, et al.
Published: (2024-10-01)

Sendaway capillary NT-proBNP in pulmonary hypertension
by: Eleanor Morris, et al.
Published: (2024-07-01)

The integration of BNP and NT-proBNP into clinical medicine
by: Swiss Medical Weekly
Published: (2007-01-01)

Highly sensitive detection of NT-proBNP by molecular motor
by: Jie Zhang, et al.
Published: (2017-03-01)

The Potential Role of Salivary NT-proBNP in Heart Failure
by: Aidonis Rammos, et al.
Published: (2023-08-01)

Economical Hematopoietic Stem Cell Transplantation with a Nationally Matched Unrelated Donor
by: Vikash Chandra Mishra, et al.
Published: (2024-12-01)

How to select the best available related or unrelated donor of hematopoietic stem cells?
by: Jean-Marie Tiercy
Published: (2016-06-01)

The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety
by: Gaganvir Parmar, et al.
Published: (2023-03-01)

Metformin therapy and circulating NT-proBNP levels: the CAMERA trial
by: Preiss, D, et al.
Published: (2016)

The role of nt-probnp in assessing the control of decompensated heart failure patients
by: Shaban, Awf Abdulrahman
Published: (2013)

The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease
by: Gina Sado, et al.
Published: (2024-12-01)

NT-proBNP and postoperative heart failure in surgery for aortic stenosis
by: Huiqi Jiang, et al.
Published: (2019-05-01)

The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease
by: Angeliki Mouzarou, et al.
Published: (2025-01-01)

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01)

LSPR-Based Aptasensor for Rapid Urinary Detection of NT-proBNP
by: Maria António, et al.
Published: (2023-07-01)

SST2 and NT-proBNP biomarkers in prediction of COVID-19
by: O.O. Samchuk, et al.
Published: (2023-06-01)

Is unrelated donor or haploidentical hematopoietic transplantation preferred for patients with acute myeloid leukemia in remission?
by: Richard Champlin
Published: (2020-02-01)

Allogeneic hematopoietic stem cell transplantation for thalassemia major using matched unrelated donors and haploidentical related donors
by: Feiyan Wang, et al.
Published: (2025-02-01)

Site U1581
by: Bohaty, SM, et al.
Published: (2023)

The association of plasma NT-proBNP level and progression of diabetic kidney disease
by: Yuancheng Zhao, et al.
Published: (2023-12-01)

NT-proBNP, Cardiometabolic Risk Factors, and Nutritional Status in Hemodialysis Patients
by: Jacques Ducros, et al.
Published: (2017-01-01)

Association between NT-proBNP Level and the Severity of COVID-19 Pneumonia
by: Lan Wang, et al.
Published: (2021-01-01)

Prognostic value of NT-proBNP in the new era of heart failure treatment.
by: Dat Vu Nguyen, et al.
Published: (2024-01-01)

Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
by: I. A. Kozlov, et al.
Published: (2023-02-01)

Analytical and clinical performance evaluation of a new NT-proBNP assay
by: Pingfeng Feng, et al.
Published: (2024-07-01)

The importance of NT proBNP in hypertensive patients management for preventing heart failure
by: Irina Cuciureanu, et al.
Published: (2021-03-01)

Longitudinal NT‐proBNP: Associations With Echocardiographic Changes and Outcomes in Heart Failure
by: Kanako Teramoto, et al.
Published: (2024-05-01)

NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure
by: Paweł Komarnicki, et al.
Published: (2023-09-01)

Optimizing Access to Unrelated Donors in Canada: Re-Examining the Importance of Donor Factors on Outcomes Following Hematopoietic Cell Transplantation
by: Gaganvir Parmar, et al.
Published: (2024-04-01)

Matched Unrelated Donor Hematopoietic Cell Transplantation: Increased Usage and Improvements in Clinical Outcomes in Canada
by: Matthew D. Seftel, et al.
Published: (2024-12-01)

Clinical Value of NT-proBNP and Lactate Parameters in Infants with Congenital Heart Defects
by: Narmin Akif Azizova
Published: (2024-11-01)

The Interplay between Adipose Tissue Properties and Levels of NT-proBNP in People with HIV
by: Mads-Holger Bang Jacobsen, et al.
Published: (2023-01-01)

Pretransplant NT‐proBNP levels are associated with mortality among lung transplant recipients
by: Shimon Izhakian, et al.
Published: (2024-07-01)

Reservoir‐excess pressure parameters are independently associated with NT‐proBNP in older adults
by: Kunihiko Aizawa, et al.
Published: (2024-10-01)

Changes in NT-proBNP levels in patients with sinus tachycardia after COVID-19
by: V. I. Podzolkov, et al.
Published: (2023-01-01)